Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × BID protein, human × Clear all

Phase

Phase 2 2 Phase 3 1 Phase 1 1

Status

Completed 7 Terminated 2 Withdrawn 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 CNS 1

Conditions

Lung Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 116 pembrolizumab 104 Specimen Handling 104 Magnetic Resonance Spectroscopy 96 fludarabine 90 Biopsy 81 Injections 52 venetoclax 43 Nivolumab 41 Bevacizumab 40 Fluorouracil 37 Paclitaxel 36 Cisplatin 36 Cetuximab 36 Carboplatin 35 fludarabine phosphate 32 Radiotherapy 32 Oxaliplatin 31 Gemcitabine 31 Leucovorin 27 Drug Therapy 25 Azacitidine 25 Ipilimumab 24 Immunotherapy, Adoptive 24 130-nm albumin-bound paclitaxel 22 atezolizumab 21 Temozolomide 20 Radiation 20 Irinotecan 20 tislelizumab 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06128148 2025-07-14

JYP0322

Guangzhou JOYO Pharma Co., Ltd

Phase 1 Recruiting

Brain Neoplasms, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡